Sullivan is a board-certified pediatrician with extensive experience in public health, health equity, primary care, infectious disease prevention and control and emergency response. Department of Health and Human Services (HHS)ĭr. Food and Drug Administration (FDA) and Meg Sullivan, MD, MPH from the Administration for Strategic Preparedness and Response (ASPR) about the risks, benefits and common side effects of these treatments.Īdministration for Strategic Preparedness and Research (ASPR) In this episode, learn from John Farley, MD, MPH from the U.S. Several treatment options are available for nursing home residents who are diagnosed with COVID-19. He has worked in academic settings teaching and caring for patients and in industry on drug development.Įpisode 2: Conversations with the CMS CMO – Long-term Care Treatment Options for COVID-19 Marks joined the FDA in 2012 as Deputy Center Director for CBER and became Center Director in January 2016. He received his graduate degree in cell and molecular biology and his medical degree at New York University and completed internal medicine residency and hematology/medical oncology training at Brigham and Women’s Hospital in Boston. To access additional infection prevention and COVID-19 vaccination and booster resources, visit our Tools & Resources.ĭirector, Center for Biologics Evaluation and Research (CBER)ĭr. To see more examples of how QIN-QIOs are working with nursing homes to improve resident COVID-19 booster rates, read the Quality in Action blog. The remaining episodes explore how nursing homes and Quality Innovation Network-Quality Improvement Organizations (QIN-QIOs) have worked together to tackle COVID-19 vaccination and infection control challenges to improve resident outcomes. Food and Drug Administration (FDA) experts.įrom the Field: Lessons Learned About Improving COVID-19 Infection Control and Vaccination/Booster Rates Lee Fleisher, the CMS CMO, nursing home leaders will hear from Centers for Disease Control and Prevention (CDC) and U.S. The first three episodes, Conversations with the CMS CMO, provide nursing homes with the facts on COVID-19 vaccines and therapeutics that support better resident outcomes. Conversations with the Centers for Medicare & Medicaid Services (CMS) Chief Medical Officer (CMO)
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |